Document is current
Any future updates will be listed below
-
Authors
E Silva-Saffar, Sacha
Mariette, Xavier
Gottenberg, Jacques-Eric
Bombardieri, Michele
Cornec, Divi
Alarcon-Riquelme, Marta E.
,
Barnes, Michael R.
Ng, Sandra
Ng, Wan-Fai
Nocturne, Gaetane
Niarakis, Anna
-
Funding
Funding for this research was provided by:
Université Paris-Saclay (Doctoral contract)
Université Paris-Saclay (Doctoral contract)
NECESSITY (GA#806975)
- License Information
-
More Information
Article History
Received: 10 September 2025
Accepted: 10 February 2026
First Online: 28 March 2026
Competing interests
: S.E.S.S.: None; X.M.: received consulting fees from B.M.S., G.S.K., Janssen, Novartis, and Pfizer; J.E.G.: None; M.B: None; D.C.: received research grants from Novartis, G.S.K., Servier, Bristol Myers Squibb, Roche-Chugai, C.S.L. Behring, and AstraZeneca; M.E.A.-R. : None; M.R.B.: None; S.N.: None; W.-F.N. received royalties from Oxford University Press for a book on Sjogren’s syndrome he has edited, provided consultations for Asahi Kasei Pharma, Amgen, Argenx, B.M.S, E.Q.T., IQVIA, Johnsons & Johnsons Innovations, Novartis, Quotients, Resolves Therapeutics, Sanofi & Veloxis; G.N. received honoraria from Biogen, Pfizer, AbbVie, Novartis, Lilly, and Amgen; A.N.: has received funding from Sanofi R&D and consulting fees from L’Oréal R&I.
